At a time when the Delta mutation is spreading and in a short time according to scientists will be the dominant strain of the coronavirus, scientists with continuous research and testing are examining the effectiveness of vaccines.
According to a report by the Times of Israel, new data from Israel and the United Kingdom show a contradictory picture regarding the effectiveness of the Pfizer vaccine in combating the "Indian" mutation. New statistics from the Israeli Ministry of Health show that, on average, the Pfizer vaccine - the vaccine given to almost all Israelis - is now only 39% effective against the infection, while it is only 41% effective in preventing Covid symptoms. Previously, the Pfizer-BioNTech vaccine was much more than 90% effective against infection.
Read also:CYPRUS: How Many Side Effects Did Vaccines Have - Mild and Severe
Meanwhile, a new UK study published this week in The New England Journal of Medicine found that the same vaccine was 88% effective in preventing symptomatic Covid - more than double the rate found in Israeli data.
Israeli statistics also appeared to paint a picture of protection weakening as months pass after vaccination. People vaccinated in January are said to have only 16% protection against infection now, while those vaccinated in April were 75% effective.
The two studies agreed, at least, that the intake was very effective in preventing serious illness, with an effectiveness of 91,4%. Some analysts have warned that data on vaccine efficacy are prone to large inaccuracies due to a number of factors, including questions about whether there are accurate data on infection levels among non-vaccinated people, which are vital for such statistics. .
Efficacy of Pfizer and AstraZeneca
At the same time, two or two doses of the Pfizer or AstraZeneca vaccine COVID-19 are about as effective against the delta variant strain of the new coronavirus, which is highly contagious, as it was against the previous dominant alpha variant, according to a study released Wednesday.
Officials say the vaccines are highly effective against the delta variant strain, which has now become the dominant variant worldwide. However, the same study points out that just one dose of vaccine is not enough for high protection.
The study, published in the New England Health Inspectorate, confirms the findings, which were briefly published in May by the Public Health System of England on the effectiveness of vaccines against COVID-19 Pfizer-BioNTech and Oxford-AstraZeneca
based on real-time data.
Yesterday's research found that two doses of the Pfizer vaccine were 88% effective in preventing the disease with symptoms from the Delta strain, compared with 93,7% against the Alpha strain, with the data being in broad lines about the same as those previously published.
Both doses of the AstraZeneca vaccine are 67% effective against the Delta variant, with this percentage being increased from the 60% protection initially reported.
The same vaccine is 74,5% effective against the variant Alpha strain, compared to the initial estimate of 66% efficacy.
"Only limited differences in vaccine efficacy were found for the variant Delta strain compared to the alpha variant strain after receiving two doses of the vaccine," the UK Health System researchers wrote in the same study.
Data from Israel have shown that the Pfizer vaccine is less effective against symptomatic illness, although protection against severe symptoms remains high.
The UK Health System has previously announced that the first dose of any of these two vaccines is approximately 33% effective against the disease with symptoms from the delta strain.
The full study published yesterday found that one dose of the Pfizer vaccine is 36% effective, while one dose of the AstraZeneca vaccine is about 30% effective.
"Our findings on reduced efficacy after the first dose will support efforts to optimize the intake of two doses among vulnerable groups within the transmissibility of the Delta variant strain," according to the study participants.
Source: Protothema.gr